Drug Pricing Analysis
🇺🇸 FDAExpert commentary and market intelligence for pharma strategy teams
Showing 1–7 of 7 articles
Medicare GLP-1 coverage 2026: Bridge program starts July 1
GLP-1 · 7 min
Dr. Sarah MitchellSupreme Court Upholds Medicare Drug Price Negotiation: Implications for Pharma
FDA · 8 min
Dr. Sarah MitchellFDA Accelerated Approval Pathway: Impact on Oncology Market Access & Pricing in 2026
FDA · oncology · 9 min
Oliver GrantBiosimilars Market Analysis: Impact of Recent FDA Approvals on US Pricing & Competition
FDA · Oncology · 10 min
James Chen, PharmDInflation Reduction Act Drug Pricing: Impact on FDA Negotiations & Innovation 2026
FDA · Pharmaceutical Market · 9 min
Dr. Emily CarterFDA Biosimilar Approval Pathway: Key Regulatory Changes & Market Impact 2026
FDA · biosimilars · 9 min
Dr. Amina FaroukAntibody-Drug Conjugates MEA: Pricing, Access & Adoption Insights 2024
SAHPRA · oncology · 11 min
Dr. Priya SharmaExplore intelligence